Viatris Connect Malaysia
  • Log-in / Register
  • Therapeutic Areas
    • Allergy
    • Cardiovascular
    • Dermatology
    • Neurology
    • Pain
    • Urology
  • Viatris Medicines
    • Log-in / Register
  • Medical News
    • Health Connect
    • Medical Journals
    • Medical Articles
  • Events
    • On-Demand Videos
  • Healthy Conversations
    • Pharmacist Modules
    • Counselling Tools
  1. Home Breadcrumb Icon
  2. Viatris Medicines
  3. Celebrex®
​Celebrex®
  • Events
  • Related Therapies

Celebrex®

Indications

Indications

Efficacy & Safety

Efficacy & Safety

Dosing & Administration

Dosing & Administration

Contraindication

Contraindication

Special Warnings & Precautions

Special Warnings & Precautions

Common Side Effects

Common Side-effects

Clinical Trial

Clinical Trial

Guidelines

Guidelines

Events

Pain Expert Celecoxib Beyond Efficacy by Dr Ozlan 2021

Related Therapies

Pain
Pain
Footer Logo

  • Contact Us
  • Adverse Events Reporting
  • Medical Information
  • Privacy Policy
  • Terms of Use
  • Cookie Policy

Copyright © 2023 Viatris Inc. All Rights Reserved.

This website is intended for healthcare professionals in Malaysia. Adverse events should be reported to Viatris by email. To report an adverse event on Viatris brands, please click here. Reporting forms and information can be found here.

Leaving the Viatris site

You are now leaving the Viatris Malaysia page for a Viatris affiliate site or third-party site that is solely responsible for its content, including its compliance with guidelines applicable in certain geographies. Links to Viatris affiliate sites and third-party sites are provided as a resource to our visitors and may not be governed by the same regulatory requirements applicable to this site and unaffiliated third-party sites are subject to their own terms and data protection notices and practices. Moreover, a third-party site is subject to other country laws, regulatory requirements, data protection requirements; medical practices may differ between countries and the information provided therein may not be suitable for use in your country.

Continue
Cancel